We describe a case of epididymo-orchitis with candiduria and histologically proven epididymal abscesses due to Candida albicans and review six previously reported cases. Candidal epididymoorchitis occurs in patients with recognized risk factors for candidal infection, often after instrumentation of the urinary tract. Cases caused by both C. albicans and Candida glabatra have been described. Drainage or orchidectomy may be required for definitive diagnosis and treatment. Treatment with oral antifungals alone has been effective in two cases.
. A, Epididymal abscess in the upper left of the microscopic field, separated from adjacent uninvolved testicular parenchyma by a fibrous tissue capsule, from a patient with candidal epididymo-orchitis. (Original magnification, 140; stain, hematoxylin-eosin.) B, High-power view showing thin septate hyphae (large arrow) with oval budding bodies (short arrow), typical of Candida species, within a background of degenerate inflammatory cells in the center of the abscess. (Original magnification, 1400; stain, Grocott-Gomori methenamine -silver.)
All but one of the patients were elderly (mean age, 69.1 rial epididymo-orchitis in men ú35 years of age, particularly after instrumentation of the urinary tract. Hematogenous disyears) and had identifiable risk factors for candidal urinary tract infection -i.e., diabetes mellitus, bladder instrumentation semination seems less likely, and in both cases where candidemia was diagnosed, the authors considered the epididymoor urinary outflow obstruction, previous broad-spectrum antibiotic therapy, or HIV infection. It therefore seems likely that orchitis to be the primary infection. Three patients, including ours, had documented negative blood cultures. the etiology of candidal epididymo-orchitis in these patients was retrograde spread of organisms from urine into the epididyAll patients presented with scrotal swelling and pain typical of epididymo-orchitis, which was bilateral in three; the duration mis. This is the usual mechanism for the development of bacte- This approach is particularly important in the setting of immuin pure growth for all patients, although three patients were receiving antibiotic treatment at the time that the first urine nosuppression, where other unusual organisms have been reported and progression to abscess formation may be more specimen was obtained. On urine microscopy, budding yeast forms were seen in five patients, and pyuria was reported in common [12] . Treatment with oral antifungals alone for 6 weeks was sucfour cases but not commented on in three. A Candida colony count of ú10,000/mL in a midstream catch urine specimen cessful in patients 1 and 2, both of whom had C. albicans isolated from urine. The success of antifungals alone in these has been used to differentiate infection from colonization, although the validity of this criterion is uncertain [8] . Colony two patients was likely not related to early diagnosis because patient 1 had symptoms for 6 weeks before receiving therapy counts were reported for four of the patients described in table 1, and three had counts of ú100,000/mL; however, one of the with oral ketoconazole. Neither of these patients had evidence of local abscess formation. In contrast, patient 6 required surgispecimens was from a catheter, which invalidates colony counts. Nevertheless, our patient's count was 10,000/mL; using cal drainage of an epididymal abscess despite the fact that he had undergone prior percutaneous drainage and had received this figure as a cutoff could lead to misdiagnosis of true infections. Although persistence of candiduria in at least two sepafluconazole. Susceptibility results were not reported for his C. glabatra isolate, although subsequent treatment with flucorate urine specimens does not imply disease, and indeed asymptomatic candiduria may persist for many months [9] , we would nazole was successful. Although there may be a role for antifungal therapy alone with close monitoring of such patients, expect that patients with candidal epididymo-orchitis would have persistent candiduria. Unfortunately, results of multiple open drainage or orchidectomy will generally be required if an abscess, pyocele, or other local complication develops, as urine examinations were reported for only two of the patients before antifungal therapy was initiated, although both had perindicated by clinical evidence of treatment failure and findings on ultrasonography. sistent candiduria.
Assays for detection of Candida antigen have variable sensiOral fluconazole, in a dose of 200 -400 mg daily for £6 weeks, is an attractive treatment option for this infection. Flucotivity but may assist in the diagnosis of disseminated candidiasis in conjunction with other laboratory and clinical features nazole has proven efficacy for candidal infections, including candidemia in nonneutropenic hosts, at a dose of 400 mg/d [10] . These assays may be of less value for patients with focal invasive candidiasis [11] , and the only patient (patient 3) for [13] . Oral administration results in high concentrations of the drug in urine and tissues, although specific data on its penetrawhom a serum Candida antigen test was reported had an equivocal result and negative blood cultures.
tion into epididymal and testicular tissue are not available [14] , and fluconazole is generally well tolerated. C. glabatra acAlthough no deaths were reported, the associated morbidity, particularly local abscess formation, was significant: orchideccounted for three of the seven isolates recovered. Isolation of this organism has therapeutic implications because of its relatomy was necessary in three cases. In addition, two patients developed candidemia. The age and/or underlying medical contive intrinsic resistance to fluconazole [15, 16] , as seen in the case of patient 5, and because of the possibility of resistance ditions of these patients may have contributed to abscess formation, but the delay in diagnosis could also have been important. developing during treatment [17] . Treatment with systemic amphotericin B, in addition to surgical drainage, was successful Where it could be determined, the initiation of antifungal therapy occurred from 5 to 10 days after the first documentation in two patients (in one of these patients, it was successful in combination with flucytosine for a fluconazole-resistant C. of candiduria and from 7 days to 5 months after the first symptoms of epididymo-orchitis. glabatra isolate). Susceptibility testing may be of value in guiding therapy, particularly with non-albicans Candida speThe delay in commencing appropriate antifungal therapy despite the presence of documented candiduria probably recies [18] , and amphotericin B, with or without flucytosine, would generally be an effective alternative agent in this situaflects the difficulty in differentiating candidal colonization from true infection. For four patients, antifungal treatment was tion.
In conclusion, we recommend that the diagnosis of candidal begun presumptively because they did not respond to antibiotic therapy. For three other patients, treatment was started after epididymo-orchitis be considered in patients with risk factors for candiduria and histories of current or recent urinary tract blood cultures or culture of an aspirate was reported to be positive. Relying on lack of response to antibacterials to diaginstrumentation who present with epidiymo-orchitis, particularly bilateral or complicated, and candiduria. Repeating a urine nose candidal epididymo-orchitis can contribute significantly to therapeutic delays. Failure to isolate a causative bacterium, culture is likely to be of benefit because if a patient's candiduria resolves, the development of candidal epidiymo-orchitis would in association with the presence of candiduria and risk factors for candidal infection, should prompt early consideration of a be unlikely. Urine cultures are usually accurate in predicting the etiology of epididymo-orchitis in this age group, and clinicians diagnosis of candidal epididymo-orchitis. For patients with / 9c4a$$ap25 03-09-98 18:11:45 cida UC: CID
